Monograph Details
|
|
Gastrointestinal Tract
> Hyperacidity, GERD, and ulcers
|
|
PROTONIX I.V. |
| Manufacturer |
|
Wyeth Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Acid pump inhibitor. |
| Generic Name |
|
Pantoprazole (as sodium) 40mg; per vial; pwd for IV infusion after reconstitution and dilution. |
| Also |
• PROTONIX for ORAL SUSP
• PROTONIX TABLETS
|
| Indications |
|
Short-term treatment of GERD, when continuation of pantoprazole tabs is not feasible. Pathological hypersecretory conditions (eg, Zollinger-Ellison syndrome). |
| Children |
|
<18 years: not recommended. |
| Adults |
|
≥18 years: GERD: 40mg once daily for 7–10 days; switch to tabs as soon as possible. Pathological hypersecretory conditions: 80mg every 8–12 hours; usual max 240mg/day or 6 days' treatment. |
| Precautions |
|
Pregnancy (Cat.B). Nursing mothers: not recommended. |
| Interactions |
|
May alter absorption of gastric pH-dependent drugs (eg, ketoconazole, iron, ampicillin). May antagonize atazanavir. Monitor warfarin. May give antacids concomitantly. IV form chelates metal ions. May cause false (+) urine THC test. |
| Adverse Reactions |
|
Headache, diarrhea, rash, hyperglycemia, dizziness, pruritus, inj site reactions; rare: cyanocobalamin deficiency. |
| How Supplied |
Tabs—90
Susp—30 packets/box
Vials (40mg)—1 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
